Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for Alopecia Areata show promise but need to be more effective and affordable.

Men over 66 taking medication for prostate enlargement have a higher risk of depression and self-harm, especially in the first 18 months of treatment.

The document concludes that cosmetic surgery is still mainly a practice for women and the gender gap in this field is expected to continue.

Women with PCOS are more likely to suffer from depression, anxiety, and stress.

Certain steroids in the brain affect mood and symptoms of depression, and treatments targeting these steroids show promise for improving these symptoms.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Androgens play a role in female sexual function, and testosterone therapy can help women with low sexual desire, but more research is needed on treatments and long-term safety.

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

Progress has been made in skin and nerve regeneration, but more research is needed to improve methods and ensure safety.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

Beta-caryophyllene helps improve wound healing in mice, especially in females.

Women with excess body hair feel psychological distress influenced by societal beauty standards, but distress isn't directly linked to the amount of hair.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

Post-finasteride patients show changed neuroactive steroid levels, possibly causing erectile dysfunction and depression.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Menopause and aging can affect women's quality of life and sexuality, but hormone therapies may help alleviate these issues.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.

Skin symptoms are important for diagnosing and managing juvenile-onset systemic lupus erythematosus and usually get better with treatment.

The VQ-Dermato is a reliable French questionnaire for measuring quality of life in chronic skin disorder patients.

Alopecia areata seriously lowers quality of life, especially affecting self-image, mental health, and social life.

The review suggests younger men taking 1 mg finasteride report more side effects, including sexual, skin, metabolic, and psychological issues.

Minoxidil effectively treats female pattern hair loss.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

A natural steroid in the body may protect against eye damage in glaucoma.